StockData
Amylyx Pharmaceuticals, Inc. logo

Amylyx Pharmaceuticals, Inc. (AMLX) stock

AMLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$26.62−0.90 (-3.27%)

Close on Nov 18, 2026Market cap $2.97BP/E –Yield –

Amylyx Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Amylyx Pharmaceuticals's pe ratio was 2.6× on Apr 30, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Apr 30, 20242.6×−538.6
2023Dec 29, 2023541.2×–

More Amylyx Pharmaceuticals figures

See a number that looks wrong?